A citation-based method for searching scientific literature

Jingyi Lu, Xiaojing Ma, Jian Zhou, Lei Zhang, Yifei Mo, Lingwen Ying, Wei Lu, Wei Zhu, Yuqian Bao, Robert A Vigersky, Weiping Jia. Diabetes Care 2018
Times Cited: 150



Robert A Vigersky, Chantal McMahon. Diabetes Technol Ther 2019
Times Cited: 116




List of shared articles



Times cited

Glucose Variability and Time in Range in Type 2 Diabetes Treated with U-500R by Pump or Injection: CGM Findings from the VIVID Study.
Thomas Blevins, Wendy Lane, David Rodbard, Dana Sindelar, Ludi Fan, Kelly Ellinor, Liza Ilag, Trang Ly, Jennal Johnson. Diabetes Technol Ther 2021
3


Association of time in range with hemoglobin A1c, glycated albumin and 1,5-anhydro-d-glucitol.
Mana Ohigashi, Keiko Osugi, Yoshiki Kusunoki, Kahori Washio, Satoshi Matsutani, Taku Tsunoda, Toshihiro Matsuo, Kosuke Konishi, Tomoyuki Katsuno, Mitsuyoshi Namba,[...]. J Diabetes Investig 2021
1

Time in range: A best practice guide for UK diabetes healthcare professionals in the context of the COVID-19 global pandemic.
E G Wilmot, A Lumb, P Hammond, H R Murphy, E Scott, F W Gibb, J Platts, P Choudhary. Diabet Med 2021
7

Time in Range in Relation to All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes: A Prospective Cohort Study.
Jingyi Lu, Chunfang Wang, Yun Shen, Lei Chen, Lei Zhang, Jinghao Cai, Wei Lu, Wei Zhu, Gang Hu, Tian Xia,[...]. Diabetes Care 2021
21


Making sense of glucose metrics in diabetes: linkage between postprandial glucose (PPG), time in range (TIR) & hemoglobin A1c (A1C).
Thomas W Martens, Richard M Bergenstal, Teresa Pearson, Anders L Carlson, Gary Scheiner, Campos Carlos, Birong Liao, Kristen Syring, Roy Daniel Pollom. Postgrad Med 2021
0

Individualizing Time-in-Range Goals in Management of Diabetes Mellitus and Role of Insulin: Clinical Insights From a Multinational Panel.
Sanjay Kalra, Shehla Shaikh, Gagan Priya, Manas P Baruah, Abhyudaya Verma, Ashok K Das, Mona Shah, Sambit Das, Deepak Khandelwal, Debmalya Sanyal,[...]. Diabetes Ther 2021
1

Characteristics of Continuous Glucose Monitoring Metrics in Persons with Type 1 and Type 2 Diabetes Treated with Multiple Daily Insulin Injections.
Sara Hallström, Irl B Hirsch, Magnus Ekelund, Sheyda Sofizadeh, Henrik Albrektsson, Solveig Dahlqvist, Ann-Marie Svensson, Marcus Lind. Diabetes Technol Ther 2021
1

Time in range centered diabetes care.
Klemen Dovc, Tadej Battelino. Clin Pediatr Endocrinol 2021
6

Continuous glucose monitoring: A review of the evidence in type 1 and 2 diabetes mellitus.
Rose Lin, Fran Brown, Steven James, Jessica Jones, Elif Ekinci. Diabet Med 2021
2

Time-in-range as a target in type 2 diabetes: An urgent need.
Banshi Saboo, Jothydev Kesavadev, Arun Shankar, Meera B Krishna, Shruti Sheth, Vidisha Patel, Gopika Krishnan. Heliyon 2021
1

The Association Between Continuous Glucose Monitoring-Derived Metrics and Cardiovascular Autonomic Neuropathy in Outpatients with Type 2 Diabetes.
Min Young Kim, Gyuri Kim, Ji Yun Park, Min Sun Choi, Ji Eun Jun, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Jae Hyeon Kim. Diabetes Technol Ther 2021
1

Association between time in range, a novel measurement of glycemic control and islet secretory function in chinese patients with type 2 diabetes mellitus-An observational study.
Shao-Ying Xu, KeLi, Zhen Zhang, Chun-Yan Liu, Qing-Yu Guo, Bin Lu, Ping Gu, Jia-Qing Shao. Diabetes Res Clin Pract 2021
0

Relationship of continuous glucose monitoring-related metrics with HbA1c and residual β-cell function in Japanese patients with type 1 diabetes.
Naru Babaya, Shinsuke Noso, Yoshihisa Hiromine, Yasunori Taketomo, Fumimaru Niwano, Sawa Yoshida, Sara Yasutake, Yumiko Kawabata, Hiroshi Ikegami. Sci Rep 2021
1


A Randomized, Open-Label Comparison of Once-Weekly Insulin Icodec Titration Strategies Versus Once-Daily Insulin Glargine U100.
Ildiko Lingvay, John B Buse, Edward Franek, Melissa V Hansen, Mette M Koefoed, Chantal Mathieu, Jeremy Pettus, Karolina Stachlewska, Julio Rosenstock. Diabetes Care 2021
8

Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial.
Harpreet S Bajaj, Richard M Bergenstal, Andreas Christoffersen, Melanie J Davies, Amoolya Gowda, Joakim Isendahl, Ildiko Lingvay, Peter A Senior, Robert J Silver, Roberto Trevisan,[...]. Diabetes Care 2021
12

Differences in Glucose Readings Between Right Arm and Left Arm Using a Continuous Glucose Monitor.
Sonoko Kawakatsu, Xiaohan Liu, Brandon Tran, Brittany P Tran, Lucy Manzanero, Eric Shih, Allen Shek, Jeremy J Lim. J Diabetes Sci Technol 2021
0

American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus.
George Grunberger, Jennifer Sherr, Myriam Allende, Thomas Blevins, Bruce Bode, Yehuda Handelsman, Richard Hellman, Rosemarie Lajara, Victor Lawrence Roberts, David Rodbard,[...]. Endocr Pract 2021
5

Time-in-range for monitoring glucose control: Is it time for a change?
Virginia Bellido, Pedro José Pinés-Corrales, Rocío Villar-Taibo, Francisco Javier Ampudia-Blasco. Diabetes Res Clin Pract 2021
0




Time in Range as a Research Outcome Measure.
Joseph G Timmons, James G Boyle, John R Petrie. Diabetes Spectr 2021
0

Leveraging advances in diabetes technologies in primary care: a narrative review.
Bruce Bode, Aaron King, David Russell-Jones, Liana K Billings. Ann Med 2021
0

Daytime Glycemic Variability and Frailty in Older Patients with Diabetes: a Pilot Study Using Continuous Glucose Monitoring.
Seung Min Chung, Yun Hee Lee, Chang Oh Kim, Ji Yeon Lee, Sang Man Jin, Seung Hyun Yoo, Jun Sung Moon, Kwang Joon Kim. J Korean Med Sci 2021
0

The Effectiveness of Traditional Chinese Medicine Jinlida Granules on Glycemic Variability in Newly Diagnosed Type 2 Diabetes: A Double-Blinded, Randomized Trial.
Jiemin Pan, Yuejie Xu, Si Chen, Yinfang Tu, Yifei Mo, Fei Gao, Jian Zhou, Cheng Hu, Weiping Jia. J Diabetes Res 2021
0

Role of Composite Glycemic Indices: A Comparison of the Comprehensive Glucose Pentagon Across Diabetes Types and HbA1c Levels.
Suresh Rama Chandran, Robert A Vigersky, Andreas Thomas, Lee Ling Lim, Jeyakantha Ratnasingam, Alexander Tan, Daphne S L Gardner. Diabetes Technol Ther 2020
5

Time in Range Is Associated with Carotid Intima-Media Thickness in Type 2 Diabetes.
Jingyi Lu, Xiaojing Ma, Yun Shen, Qiang Wu, Ren Wang, Lei Zhang, Yifei Mo, Wei Lu, Wei Zhu, Yuqian Bao,[...]. Diabetes Technol Ther 2020
49

Critical Reappraisal of the Time-in-Range: Alternative or Useful Addition to Glycated Hemoglobin?
Lutz Heinemann, Guido Freckmann, Dirk Müller-Wieland, Monika Kellerer. J Diabetes Sci Technol 2020
3

Longitudinal Analysis of Real-World Performance of an Implantable Continuous Glucose Sensor over Multiple Sensor Insertion and Removal Cycles.
Katherine S Tweden, Dorothee Deiss, Ravi Rastogi, Suresh Addaguduru, Francine R Kaufman. Diabetes Technol Ther 2020
4


Impact of free-living pattern of sedentary behaviour on intra-day glucose regulation in type 2 diabetes.
Aye C Paing, Kathryn A McMillan, Alison F Kirk, Andrew Collier, Allan Hewitt, Sebastien F M Chastin. Eur J Appl Physiol 2020
3

Improved glycaemic variability and time in range with dapagliflozin versus gliclazide modified release among adults with type 2 diabetes, evaluated by continuous glucose monitoring: A 12-week randomized controlled trial.
Andre G D Vianna, Claudio S Lacerda, Luciana M Pechmann, Michelle G Polesel, Emerson C Marino, Mauro Scharf, Josiane M Detsch, Kleber Marques, Claudia P Sanches. Diabetes Obes Metab 2020
3

Clinical Recommendations for the Use of the Ambulatory Glucose Profile in Diabetes Care.
Jens Kröger, Andreas Reichel, Thorsten Siegmund, Ralph Ziegler. J Diabetes Sci Technol 2020
6


HbA1c: The Glucose Management Indicator, Time in Range, and Standardization of Continuous Glucose Monitoring Reports in Clinical Practice.
Anders L Carlson, Amy B Criego, Thomas W Martens, Richard M Bergenstal. Endocrinol Metab Clin North Am 2020
12

Glycemic variability modifies the relationship between time in range and hemoglobin A1c estimated from continuous glucose monitoring: A preliminary study.
Jingyi Lu, Xiaojing Ma, Lei Zhang, Yifei Mo, Wei Lu, Wei Zhu, Yuqian Bao, Weiping Jia, Jian Zhou. Diabetes Res Clin Pract 2020
8

Time in Range, as a Novel Metric of Glycemic Control, Is Reversely Associated with Presence of Diabetic Cardiovascular Autonomic Neuropathy Independent of HbA1c in Chinese Type 2 Diabetes.
Qingyu Guo, Pu Zang, Shaoying Xu, Wenjing Song, Zhen Zhang, Chunyan Liu, Zhanhong Guo, Jing Chen, Bin Lu, Ping Gu,[...]. J Diabetes Res 2020
20